Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Putting equity first: reorienting artificial intelligence for population-level postpartum depression prevention.

Created on 01 Nov 2026

Authors

Ya-Li Yan, Qian-Qian Li, Meng Xu

Published in

Frontiers in public health. Volume 14. Pages 1967813. Epub Sep 25, 2026.

Abstract

Postpartum depression (PPD) affects 10-20% of new mothers globally, yet detection and treatment rates remain low, particularly in underserved populations. Artificial intelligence (AI)-here spanning supervised machine-learning prediction, natural-language and acoustic analysis, and generative conversational agents-is increasingly promoted as a solution, from risk prediction to chatbot-delivered therapy. Drawing on selected evidence from clinical informatics, digital mental health, public-health ethics, and implementation science, we argue that although AI may genuinely expand reach, its current trajectory, driven by technical feasibility rather than public-health value, could widen rather than narrow maternal mental-health inequities. This risk plays out across four domains: (1) algorithmic accuracy that does not translate into population outcomes; (2) training data that structurally exclude marginalized groups; (3) algorithmic care that may erode relational support; and (4) a regulatory vacuum that permits deployment without accountability. Distinguishing published evidence from our own recommendations, we conclude that AI for PPD prevention should be governed as a public good through equity-centered design, real-world evidence standards (including calibration and subgroup performance beyond AUC), tiered device oversight, layered data consent, and clearly specified safety pathways. We call for a global dialogue among policymakers, developers, health systems, researchers, and women with lived experience to operationalize these principles before large-scale deployment.

PMID:
42857035
Bibliographic data and abstract were imported from PubMed on 01 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 30
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement